Cash Flow StemCell Institute Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
No of Months
12
12
12
12
12
12
Profit Before Tax
565.00
441.00
278.00
212.00
91.00
382.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
57.00
-93.00
-195.00
136.00
238.00
347.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
467.00
334.00
99.00
469.00
238.00
667.00
Cash Flow from Investing Activities
-259.00
-811.00
-285.00
404.00
-520.00
-108.00
Cash Flow from Financing Activities
146.00
-1.00
0.00
644.00
0.00
0.00
Net Cash Inflow / Outflow
355.00
-478.00
-186.00
1,517.00
-281.00
559.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in JPY Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of StemCell Institute
Figures in Million
consolidated Cash Flow Results
Change(JPY)
Change(%)
Profit Before Tax
565.712
-356.205
921.00
258.82%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
57.181
99.989
-42.00
-42.81%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
467.685
-230.762
697.00
302.67%
Cash Flow from Investing Activities
-259.084
-8.528
-251.00
-2938.04%
Cash Flow from Financing Activities
146.704
37.372
109.00
292.55%
Net Cash Inflow / Outflow
355.305
-201.918
556.00
275.96%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
0
0.00
0.00%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Mar'25
YoY Growth in year ended Mar 2025 is 39.76% vs 235.73% in Mar 2024
Mar'25
Mar'24
Change(%)
Cash Flow from Operating Activities
467.69
334.62
39.76%
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
